by PEAK Medicals | 25 June 2025
IO in early stage & combinations in late NSCLC LESS IS MORE – NEOADJUVANT IO ALONE IS UNDOUBTEDLY SUFFICIENT Patrick Forde EMBRACING ADDITIONAL ADJUVANT IO: A CRUCIAL AND NECESSARY ADD-ON Jordi Remon MAXIMIZING OUTCOMES: THE ROLE OF IO COMBINATIONS Solange Peters...
by PEAK Medicals | 17 June 2025
Agenda & Discussion Topics THE EMERGING ROLE OF DLL3 T-CELL ENGAGERS IN SCLC Giannis Mountzios EXPANDING OUR OPTIONS WITH IO COMBINATION THERAPIES IN LS- AND ES-SCLC Jacob Sands Open Discussion, Viewer Questions & Patient Cases Solange Peters  17 June 2025 }...
by PEAK Medicals | 4 October 2024
Patient Cases & Open Questions All Panelists & Faculty Members  04 October 2024 } 32...
by PEAK Medicals | 4 October 2024
Reshaping Our Approaches in SCLC: Latest Therapeutic Options and Future Strategies Stephen V. Liu USA  04 October 2024 } 25 min Download...
by PEAK Medicals | 4 October 2024
DEBATE: Balancing Efficacy, Toxicity, and Patient-Centered Care For IO Duration in NSCLC Giannis Mountzios (Greece) Sandip Patel (USA)  04 October 2024 } 33 min Download...
